Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking ...

AstraZeneca Pharma share price: This approval allows the use of Durvalumab in combination with Tremelimumab, broadening treatment options for patients battling advanced-stage liver cancer ...

March 21 (UPI) --AstraZeneca plans to build a $2.5 billion research and development center in Beijing, the Britain-based multinational pharmaceutical announced Friday. The investment will mark the ...